课题基金 / 基金详情

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY This application is requesting funds to purchase a Formulatrix ROCK IMAGER® 2 with Dual Light Path and capable of both ultraviolet (UV) and multi-fluorescence imaging to monitor and capture high-throughput crystallization screening experiments. The primary application of the new imager will be to accelerate crystallization screening in the institutional Advanced Technology Core (ATC) for Macromolecular X-ray Crystallography at Baylor College of Medicine (BCM). The ROCK IMAGER 2 will replace the existing imaging system that was purchased in 2008, and will be no longer maintained or serviced by the manufacturer. The new imager will enhance the capabilities of the X-ray Core by enabling the rapid screening of protein crystals and crystals of fluorescently-labeled macromolecular complexes. In addition to the seven Major Users, who are experienced with protein crystallization or use X-ray crystallography for their research, four Minor Users have expressed interest in using the ROCK IMAGER 2 for crystallization screening through the Macromolecular X-ray Crystallography ATC. Besides BCM, there are only two other academic institutions in the Texas Medical Center (TMC) possessing an imaging system, neither of which is available for use by Core Staff. The requested instrument will be housed and managed by the X-ray Core to provide major services for the crystallization of proteins and their functional complexes with nucleic acids, small molecules, or both. The growing demand to discover new drugs reflects the College’s strategic plans for precision medicine and translational research, where health professionals and basic researchers come together to develop new therapeutics against emerging infectious diseases, diabetes and obesity, male contraceptive, cancer, and Alzheimer's disease. In addition to greatly enhancing the Core's workflow, the new imager will advance the individual research programs of users and will be made available to all investigators in the TMC to help find a structure solution of their macromolecule of interest.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/acsinfecdis.3c00565
发表时间: 2024-01
期刊: ACS infectious diseases
影响因子: 5.3
作者: [M. Ashraf-Uz-Zaman;Teck Khiang Chua;Xin Li;Yuan Yao;Bala Krishna Moku;Chandra Bhushan Mishra;V. Avadhanula;P. Piedra;Yongcheng Song]
通讯作者: M. Ashraf-Uz-Zaman;Teck Khiang Chua;Xin Li;Yuan Yao;Bala Krishna Moku;Chandra Bhushan Mishra;V. Avadhanula;P. Piedra;Yongcheng Song
DOI: 10.7554/elife.79530
发表时间: 2022-08-05
期刊: ELIFE
影响因子: 7.7
作者: [Sharma, Rajesh, Kim, Jeong Joo, Qin, Liying, Henning, Philipp, Akimoto, Madoka, VanSchouwen, Bryan, Kaur, Gundeep, Sankaran, Banumathi, MacKenzie, Kevin R., Melacini, Giuseppe, Casteel, Darren E., Herberg, Friedrich W., Kim, Choel]
通讯作者: Kim, Choel
Structural basis of impaired disaggregase function in the oxidation-sensitive SKD3 mutant causing 3-methylglutaconic aciduria.
在氧化敏感的SKD3突变体中分解酶函数受损的结构基础,导致3-甲基谷氨酸酸尿。
DOI: 10.1038/s41467-023-37657-9
发表时间: 2023-04-11
期刊: NATURE COMMUNICATIONS
影响因子: 16.6
作者: [Lee, Sukyeong, Lee, Sang Bum, Sung, Nuri, Xu, Wendy W., Chang, Changsoo, Kim, Hyun-Eui, Catic, Andre, Tsai, Francis T. F.]
通讯作者: Tsai, Francis T. F.
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究